Mexidol® - standard of antioxidant neurocytoprotection
- 00:00
The basis of vascular diseases
- 01:05
Decrease in mortality from cardiovascular diseases and the problem of comorbidity
- 02:12
Mexidol® and its role in reducing the ischemia zone
- 03:19
The presentation of the Nobel Prize in Chemistry N.N. Semenov and the idea of creating the drug Mexidol®
- 04:26
Mexidol® is an original drug with antioxidant properties and anti -enyal activity
- 05:56
Mexidol® - action and wide application
- 07:28
Mexidol® is a proven drug with a huge clinical base
- 08:32
Differences in the Mexidol® brand and analogues
- 09:42
Awards and rating among drugs for neurological practice
Oganov Rafael Gegamovich - MD, academician of the Russian Academy of Sciences, professor, honorary president of the Russian Cardiological Society
Voronina Tatyana Aleksandrovna - MD , professor, head. Laboratory of psychopharmacology of the FSBBNU of the Nii pharmacology named after V.V. Kaszova
Fedin Anatoly Ivanovich - MD, honorary professor, head of the university clinic of neurology RNIMU named after N.I. Pirogova, Honored Doctor of the Russian Federation
Zhivolupov Sergey Anatolyevich -MD, professor at the Department of Nervous Diseases of the Military Medical Academy named after CM. Kirov
Announcement:
The ischemic process of the heart muscle is the pathogenetic basis of such common diseases as acute myocardial infarction, stable and unstable angina pectoris. An acute or chronic decrease in blood supply to tissues and organs leads to hypoxia and, as a result, energy deficiency, oxidative stress, which may occur irreversible changes in the cell and its death. Understanding the mechanisms of the formation of free radicals became the foundation for creating the concept of combating tissue ischemia and developing a unique domestic drug. Mexidol® is the achievement of the Institute of Pharmacology of the Russian Academy of Medical Sciences. The drug is a combination of two functionally related compounds-3-oxypyridine and succinate. The main pharmacological effects of the drug Mexidol® include antioxidant, antihypoxic and membrane -stabilizing. For many years of clinical use, Mexidol ® has received recognition from the medical community and is rightfully considered the standard of antioxidant cardio and neurocytoprotexts.
- 00:00
The basis of vascular diseases
- 01:05
Decrease in mortality from cardiovascular diseases and the problem of comorbidity
- 02:12
Mexidol® and its role in reducing the ischemia zone
- 03:19
The presentation of the Nobel Prize in Chemistry N.N. Semenov and the idea of creating the drug Mexidol®
- 04:26
Mexidol® is an original drug with antioxidant properties and anti -enyal activity
- 05:56
Mexidol® - action and wide application
- 07:28
Mexidol® is a proven drug with a huge clinical base
- 08:32
Differences in the Mexidol® brand and analogues
- 09:42
Awards and rating among drugs for neurological practice
Block of articles on this topic
Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.
Source of photos and images Shutterstock.com